Annual Total Liabilities
$1.44 M
-$1.25 M-46.42%
December 31, 2023
Summary
- As of February 7, 2025, TTNP annual total liabilities is $1.44 million, with the most recent change of -$1.25 million (-46.42%) on December 31, 2023.
- During the last 3 years, TTNP annual total liabilities has fallen by -$3.11 million (-68.30%).
- TTNP annual total liabilities is now -96.99% below its all-time high of $47.95 million, reached on December 31, 2012.
Performance
TTNP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$371.00 K
+$15.00 K+4.21%
September 30, 2024
Summary
- As of February 7, 2025, TTNP quarterly total liabilities is $371.00 thousand, with the most recent change of +$15.00 thousand (+4.21%) on September 30, 2024.
- Over the past year, TTNP quarterly total liabilities has dropped by -$1.07 million (-74.31%).
- TTNP quarterly total liabilities is now -99.23% below its all-time high of $47.95 million, reached on December 31, 2012.
Performance
TTNP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TTNP Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -46.4% | -74.3% |
3 y3 years | -68.3% | -84.8% |
5 y5 years | -80.1% | -90.3% |
TTNP Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -49.4% | at low | -87.0% | +4.2% |
5 y | 5-year | -82.2% | at low | -95.8% | +4.2% |
alltime | all time | -97.0% | at low | -99.2% | +4.2% |
Titan Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $371.00 K(+4.2%) |
Jun 2024 | - | $356.00 K(-36.3%) |
Mar 2024 | - | $559.00 K(-61.3%) |
Dec 2023 | $1.44 M(-46.4%) | $1.44 M(-22.6%) |
Sep 2023 | - | $1.87 M(+1.1%) |
Jun 2023 | - | $1.85 M(-25.6%) |
Mar 2023 | - | $2.48 M(-8.0%) |
Dec 2022 | $2.69 M(-5.6%) | $2.69 M(-1.1%) |
Sep 2022 | - | $2.73 M(+2.8%) |
Jun 2022 | - | $2.65 M(+8.9%) |
Mar 2022 | - | $2.44 M(-14.7%) |
Dec 2021 | $2.86 M(-37.3%) | $2.86 M(+33.4%) |
Sep 2021 | - | $2.14 M(-22.4%) |
Jun 2021 | - | $2.76 M(-28.2%) |
Mar 2021 | - | $3.84 M(-15.6%) |
Dec 2020 | $4.55 M(-43.7%) | $4.55 M(-48.9%) |
Sep 2020 | - | $8.91 M(+8.7%) |
Jun 2020 | - | $8.20 M(+2.7%) |
Mar 2020 | - | $7.99 M(-1.3%) |
Dec 2019 | $8.09 M(+11.4%) | $8.09 M(+1.6%) |
Sep 2019 | - | $7.96 M(+8.6%) |
Jun 2019 | - | $7.33 M(-12.6%) |
Mar 2019 | - | $8.38 M(+15.4%) |
Dec 2018 | $7.26 M(-9.7%) | $7.26 M(+14.1%) |
Sep 2018 | - | $6.37 M(+7.3%) |
Jun 2018 | - | $5.93 M(-3.4%) |
Mar 2018 | - | $6.14 M(-23.8%) |
Dec 2017 | $8.05 M(+47.0%) | $8.05 M(-7.5%) |
Sep 2017 | - | $8.70 M(+363.9%) |
Jun 2017 | - | $1.88 M(-24.0%) |
Mar 2017 | - | $2.47 M(-54.9%) |
Dec 2016 | $5.48 M(-13.0%) | $5.48 M(-33.8%) |
Sep 2016 | - | $8.27 M(+8.6%) |
Jun 2016 | - | $7.62 M(+16.8%) |
Mar 2016 | - | $6.52 M(+3.5%) |
Dec 2015 | $6.30 M(-48.6%) | $6.30 M(+5.1%) |
Sep 2015 | - | $5.99 M(-60.9%) |
Jun 2015 | - | $15.33 M(+8.0%) |
Mar 2015 | - | $14.20 M(+16.0%) |
Dec 2014 | $12.24 M(-3.3%) | $12.24 M(+36.5%) |
Sep 2014 | - | $8.96 M(-16.9%) |
Jun 2014 | - | $10.79 M(-8.9%) |
Mar 2014 | - | $11.84 M(-6.5%) |
Dec 2013 | $12.66 M(-73.6%) | $12.66 M(-12.7%) |
Sep 2013 | - | $14.50 M(-1.8%) |
Jun 2013 | - | $14.76 M(-44.5%) |
Mar 2013 | - | $26.58 M(-44.6%) |
Dec 2012 | $47.95 M(+58.3%) | $47.95 M(+26.6%) |
Sep 2012 | - | $37.88 M(+14.6%) |
Jun 2012 | - | $33.05 M(+5.9%) |
Mar 2012 | - | $31.20 M(+3.0%) |
Dec 2011 | $30.30 M(+180.4%) | $30.30 M(+25.7%) |
Sep 2011 | - | $24.10 M(-6.7%) |
Jun 2011 | - | $25.83 M(+89.3%) |
Mar 2011 | - | $13.64 M(+26.3%) |
Dec 2010 | $10.80 M | $10.80 M(+1.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $10.70 M(+152.8%) |
Jun 2010 | - | $4.23 M(-45.9%) |
Mar 2010 | - | $7.83 M(+99.0%) |
Dec 2009 | $3.93 M(-7.6%) | $3.93 M(-13.7%) |
Sep 2008 | - | $4.55 M(-9.7%) |
Jun 2008 | - | $5.04 M(+14.6%) |
Mar 2008 | - | $4.40 M(+3.4%) |
Dec 2007 | $4.26 M(+25.4%) | $4.26 M(+47.6%) |
Sep 2007 | - | $2.88 M(-11.2%) |
Jun 2007 | - | $3.25 M(-1.7%) |
Mar 2007 | - | $3.30 M(-2.7%) |
Dec 2006 | $3.39 M(+8.2%) | $3.39 M(-18.0%) |
Sep 2006 | - | $4.14 M(+38.0%) |
Jun 2006 | - | $3.00 M(-6.7%) |
Mar 2006 | - | $3.21 M(+2.5%) |
Dec 2005 | $3.14 M(-14.6%) | $3.14 M(-30.1%) |
Sep 2005 | - | $4.49 M(+30.9%) |
Jun 2005 | - | $3.43 M(-23.2%) |
Mar 2005 | - | $4.47 M(+21.7%) |
Dec 2004 | $3.67 M(+9.9%) | $3.67 M(+10.5%) |
Sep 2004 | - | $3.32 M(+26.2%) |
Jun 2004 | - | $2.63 M(-36.9%) |
Mar 2004 | - | $4.17 M(+24.9%) |
Dec 2003 | $3.34 M(-15.3%) | $3.34 M(-11.7%) |
Sep 2003 | - | $3.79 M(-5.2%) |
Jun 2003 | - | $3.99 M(+1.4%) |
Mar 2003 | - | $3.94 M(-0.3%) |
Dec 2002 | $3.94 M(-31.6%) | $3.94 M(+15.4%) |
Sep 2002 | - | $3.42 M(-9.1%) |
Jun 2002 | - | $3.76 M(+8.2%) |
Mar 2002 | - | $3.47 M(-39.7%) |
Dec 2001 | $5.76 M(+134.0%) | $5.76 M(+128.7%) |
Sep 2001 | - | $2.52 M(-13.5%) |
Jun 2001 | - | $2.91 M(+11.2%) |
Mar 2001 | - | $2.62 M(+6.4%) |
Dec 2000 | $2.46 M(+29.6%) | $2.46 M(-17.2%) |
Sep 2000 | - | $2.98 M(+88.4%) |
Jun 2000 | - | $1.58 M(-28.2%) |
Mar 2000 | - | $2.20 M(+15.7%) |
Dec 1999 | $1.90 M(+18.8%) | $1.90 M(+58.3%) |
Sep 1999 | - | $1.20 M(-29.4%) |
Jun 1999 | - | $1.70 M(+6.3%) |
Mar 1999 | - | $1.60 M(0.0%) |
Dec 1998 | $1.60 M(-77.8%) | $1.60 M(+33.3%) |
Sep 1998 | - | $1.20 M(0.0%) |
Jun 1998 | - | $1.20 M(-14.3%) |
Mar 1998 | - | $1.40 M(-80.6%) |
Dec 1997 | $7.20 M(+89.5%) | $7.20 M(-8.9%) |
Sep 1997 | - | $7.90 M(-21.0%) |
Jun 1997 | - | $10.00 M(-9.9%) |
Mar 1997 | - | $11.10 M(+192.1%) |
Dec 1996 | $3.80 M(-59.1%) | $3.80 M(+11.8%) |
Sep 1996 | - | $3.40 M(-5.6%) |
Jun 1996 | - | $3.60 M(-14.3%) |
Mar 1996 | - | $4.20 M(-54.8%) |
Dec 1995 | $9.30 M | $9.30 M |
FAQ
- What is Titan Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual total liabilities year-on-year change?
- What is Titan Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly total liabilities year-on-year change?
What is Titan Pharmaceuticals annual total liabilities?
The current annual total liabilities of TTNP is $1.44 M
What is the all time high annual total liabilities for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual total liabilities is $47.95 M
What is Titan Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, TTNP annual total liabilities has changed by -$1.25 M (-46.42%)
What is Titan Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of TTNP is $371.00 K
What is the all time high quarterly total liabilities for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly total liabilities is $47.95 M
What is Titan Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, TTNP quarterly total liabilities has changed by -$1.07 M (-74.31%)